Clinical Trial

Clinical Trials of IBI3040 in Healthy Participants and Overweight or Obese Participants

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
Clinical trials of IBI3040 with single-dose administration in healthy participants and multiple-dose administration in overweight or obese participants.
Trial Details
NCT Number NCT07765160
Lead Sponsor Innovent Biologics (Suzhou) Co. Ltd.
Conditions Healthy Participants, Overweight or Obese Participants
Enrollment 96 participants
Start Date 2026-08-30
Primary Completion 2027-11-10 (estimated)
Study Completion 2027-12-10 (estimated)
Updated on ClinicalTrials.gov 2026-08-14